GEORGE YANCOPOULOS - 02 Jan 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**George D. Yancopoulos
Issuer symbol
REGN
Transactions as of
02 Jan 2024
Transactions value $
$-15,163,200
Form type
4
Filing time
04 Jan 2024, 16:20:19 UTC
Previous filing
13 Dec 2023
Next filing
20 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $-15,163,200 -16,848 -8.56% $900.00 180,000 02 Jan 2024 By Trust for Chldn. F1, F2
holding REGN Common Stock 752,486 02 Jan 2024 Direct
holding REGN Common Stock 5,889 02 Jan 2024 By 401(k) Plan
holding REGN Common Stock 121,071 02 Jan 2024 by 2022 GRAT I
holding REGN Common Stock 158,410 02 Jan 2024 by 2022 GRAT II
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022.
F2 As investment trustee of trusts for the benefit of the reporting person's children.